• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

3 Facts Proving The Future of Google Glass in Healthcare is Brighter Than Ever

by Kyle Samani 01/30/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Google Glass in Healthcare

Kyle Samani Google Glass in Healthcare
Kyle Samani, CEO at Pristine

There have been tons of recent reports and op-eds following recent announcements from Google about the changes to the Glass program. Unfortunately, much of the reporting has been misleading. Let’s start by getting the facts straight, then consider what’s next for Glass.

Facts:

1) Glass is “graduating” from Google[x], the company’s research division, and becoming a full-fledged business unit within Google proper.

2) The new business unit will be overseen by Tony Fadell, who led the iPod division at Apple before he created the Nest thermostat.

3) The consumer-focused Glass Explorer program has ended and the general public will not be able to purchase Glass anymore (though enterprise partners like Pristine and Augmedix have unrestricted access to as many Glass units as needed).

Together, these facts signal a bright future for Glass.

As a true, non-experimental business unit within Google, the Glass team will enjoy far greater resources than before. This will come in the form of larger budgets, more manpower and greater ability to leverage Google’s talent pool across the organization, from engineering to marketing and everything in between.

Fadell is widely regarded as one of the best consumer hardware executives of the modern era, with $2 billion-plus successes under his belt (iPod and Nest). The assignment of Google’s top hardware talent to Glass is a shrewd move by Larry Page, and one that bodes well for the future.

The end of the Explorer Program is an indication of the next phase of Glass’ growth. Ending the public beta program was a prerequisite of any future release of new Glass hardware. With the experimentation phase of the Glass project complete, Google can now apply those learnings to the creation of future Glass devices.

Beyond Google’s internal initiatives, we’re also seeing the effects of Google’s investment in its partner ecosystem. As a Certified Partner, Pristine has been fortunate to partner with Google and witness the rapid investment of resources into the Glass at Work program. The Glass at Work team is growing fast and working hard to encourage innovative and powerful uses of the technology.

Pristine clients are connecting mothers and infants in the NICU, leading the way in new models for medical device support, providing a brand-new clinical perspective in medical education, and much more. For our part, we’re proud to power many of these pioneering uses for Glass. But we’re still in the early chapters of the story. There are incredible opportunities on the horizon, and we can see them through Glass.

Kyle Samani is the Founder and CEO of Pristine, a company based out of Austin, TX that’s delivering the next generation of telehealth through Google Glass.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |